As of 12:50pm ET
| -0.11 / -2.42%|
The 3 analysts offering 12-month price forecasts for Cascadian Therapeutics Inc have a median target of 13.00, with a high estimate of 13.00 and a low estimate of 4.00. The median estimate represents a +193.45% increase from the last price of 4.43.
The current consensus among 4 polled investment analysts is to Buy stock in Cascadian Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.